Metabolic Processes in Adults and Adolescents With Autism Spectrum Disorder

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 3, 2015

Primary Completion Date

October 30, 2017

Study Completion Date

October 30, 2017

Conditions
Autism Spectrum Disorder
Interventions
OTHER

stable isotope infusion

stable isotopes such as 15N2, TRP, 2H3-Leucine, L-\[2H3\]-3-Methylhistidine, 2H2-Glycine, 2-D-hydroxyproline, 1-13C-ketoisocaproic acid (KIC), L-\[Guanido-15N2\]-Arginine, L-\[ureido-13C-2H2\]-Citrulline), L-Glutamine-amide-15N, 1,2-13C2-L-Glutamic acid, 1,2-13C2Taurine, and 13C-Urea is given IV simultaneously

Trial Locations (1)

77843

Texas A&M University-CTRAL, College Station

All Listed Sponsors
lead

Texas A&M University

OTHER

NCT02733120 - Metabolic Processes in Adults and Adolescents With Autism Spectrum Disorder | Biotech Hunter | Biotech Hunter